GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (OSTO:ULTIo) » Definitions » Research & Development

Zelluna ASA (OSTO:ULTIO) Research & Development : kr88.68 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Zelluna ASA Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Zelluna ASA's Research & Development for the three months ended in Dec. 2024 was kr26.60 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was kr88.68 Mil.

Zelluna ASA Research & Development Historical Data

The historical data trend for Zelluna ASA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelluna ASA Research & Development Chart

Zelluna ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.66 96.74 95.18 123.83 88.68

Zelluna ASA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.24 21.63 26.27 14.18 26.60

Zelluna ASA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr88.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zelluna ASA  (OSTO:ULTIo) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Zelluna ASA Research & Development Related Terms

Thank you for viewing the detailed overview of Zelluna ASA's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Zelluna ASA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (OSTO:ULTIo) » Definitions » Research & Development
Comparable Companies
OSL:LYTIX OSL:SOFTX OSL:EXTX OSL:ONCIN OSL:ABS OSL:ABTEC OSL:BGBIO OSL:CRNA OSL:PCIB OSL:HBC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
ZLNA:Norway 7UM0:Germany
Address
Ullernchausseen 64, Oslo, NOR, 0379
Website
https://www.zelluna.com
Zelluna ASA is a clinical-stage biotechnology company developing novel immunotherapies against cancer and the development of T-Cell Receptor Natural Killer cell therapies for the treatment of solid cancers. The company's current pipeline consists of allogeneic TCR-NK R&D programs ZI-MA4-1, ZI-KL1-1, and ZI-PR-1 targeting well validated antigens expressed across a broad range of solid tumors.

Zelluna ASA Headlines

No Headlines